Researchers develop gene classifier to predict DCIS risk of cancer progression

A team of researchers mapping a molecular atlas for ductal carcinoma in situ (DCIS) has made a major advance toward distinguishing whether the early pre-cancers in the breast will develop into invasive cancers or remain stable.

Pharmacies fear New Year’s financial squeeze from Biden administration rule

WASHINGTON — The Biden administration seemed to be giving pharmacies a win when they forced pharmacy benefit managers to be more up-front about the behind-the-scenes

January 2, 2024

Gastroenteritis Rates Higher in Seine Events Than in Previous Olympics

Athletes who swam in the Seine during the Olympic games in Paris had higher rates of gastroenteritis than those in games past, a U.S. Olympic

August 22, 2024

Pharmalittle: We are reading about Catalent concerns, a congressional hearing, and more

Good morning, everyone, and how are you today? We are doing just fine, thank you, especially given the crystal clear blue skies and a warm

February 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.